TISSUE & FFPE COHORT COLLECTIONS

Breast cancer tissue microarrays & FFPE blocks

Compare breast cancer arrays by receptor profile, tissue composition and available clinical records. Collections include ER-positive disease, triple-negative breast cancer, and selected primary and matched metastatic tissue. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Breast cancer arrays (27)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Breast cancer FFPE blocks for your study

Breast cancer and TNBC cohorts with receptor, treatment, metastatic or matched-plasma information.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

FFPE TISSUE COHORTS

Breast cancer FFPE cohorts

Select a cohort or patient profile, then share your sample and data requirements with our team.

Cohort #26

Breast Cancer (non-TNBC) with histopath data

Cohort #27

Breast cancer pre and post treatment, includes ER+, ER-, Her2(+), Her2(-), TNBC; donor unmatched samples with follow up data

Cohort #28

Breast cancer primary & matched nodal & distant mets with survival data

Cohort #180

Breast cancer with matched double spun plasma

Cohort #30

Breast cancers ER+ (relapsed) with follow up information

Cohort #31

TNBC (III/IV) with ER,PR,Her2 & histopath data

Cohort #32

TNBC post treatment with follow up data

Cohort #33

TNBC primary & Mets with follow up data

Cohort #35

TNBC with ER,PR,Her2 & survival data

Cohort #36

TNBC with ER,PR,Her2, CA9 & histopath data

Cohort #37

Triple negative breast cancer (TNBC) with histopath data

Cohort #38

Herceptin eligible breast cancer with histopath data

Breast cancer · Patient profile

TNBC across all stages, including metastatic disease

Breast cancer · Patient profile

Breast cancer stages I–III

Breast cancer · Patient profile

Before or after CDK4/6 inhibitor treatment

Breast cancer · Patient profile

BRCA1/2- or PALB2-mutated, HR-positive / HER2-negative advanced disease

Breast cancer · Patient profile

ER-positive / HER2-negative advanced disease

Breast cancer · Patient profile

HER2-negative, BRCA-mutated neoadjuvant cohorts

Breast cancer · Patient profile

HER2-positive metastatic disease

SELECTING YOUR ARRAY

Select the breast cancer context your study needs

Receptor profile, treatment setting and donor matching describe different aspects of an array. Check each against your study requirements.

TA2210 tissue composition

TNBC (III/IV) with ER,PR,Her2 & histopath data.

TA2270 tissue composition

TNBC with ER,PR,Her2 & survival data (TA2270).

TA2273 tissue composition

TNBC with ER,PR,Her2, CA9 & histopath data (TA2273).